CLH Stock Overview
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
Cardinal Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$98.86 |
| 52 Week High | US$106.30 |
| 52 Week Low | US$71.72 |
| Beta | 0.70 |
| 1 Month Change | -1.73% |
| 3 Month Change | 2.74% |
| 1 Year Change | 36.32% |
| 3 Year Change | 95.30% |
| 5 Year Change | 147.77% |
| Change since IPO | 193.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLH | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -2.7% | 1.3% | -1.2% |
| 1Y | 36.3% | -6.5% | 1.2% |
Return vs Industry: CLH exceeded the German Healthcare industry which returned -6.5% over the past year.
Return vs Market: CLH exceeded the German Market which returned 1.2% over the past year.
Price Volatility
| CLH volatility | |
|---|---|
| CLH Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 9.8% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: CLH has not had significant price volatility in the past 3 months.
Volatility Over Time: CLH's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 47,520 | Jason Hollar | www.cardinalhealth.com |
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical.
Cardinal Health, Inc. Fundamentals Summary
| CLH fundamental statistics | |
|---|---|
| Market cap | €24.03b |
| Earnings (TTM) | €600.60m |
| Revenue (TTM) | €203.16b |
40.0x
P/E Ratio0.1x
P/S RatioIs CLH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLH income statement (TTM) | |
|---|---|
| Revenue | US$216.15b |
| Cost of Revenue | US$208.92b |
| Gross Profit | US$7.23b |
| Other Expenses | US$6.59b |
| Earnings | US$639.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 2.63 |
| Gross Margin | 3.34% |
| Net Profit Margin | 0.30% |
| Debt/Equity Ratio | -137.0% |
How did CLH perform over the long term?
See historical performance and comparison